20xx年醫(yī)學(xué)專題—婦科相關(guān)論文-(10)-資料下載頁
2024-11-19 05:24本頁面
【正文】 ossover M,Quakernack J,Chiantera LANN technique to reduce postoperative functional morbidity in laparoscopic radical pelvic surgery[J].J Am Coll Surg，2005，201(6):913917. [25] Van den Tillaart SA,Kenter GG,Peters AA,et sparing radical hysterectomy:local recurrence rate,feasibility,and safety in cervical cancer patients stage ⅠA to ⅡA[J].Int J Gynecol Cancer,2009,19(1):3945. [26] Magrina JF,Kho R,Magtibay radical hysterectomy:technical aspects[J].Gynecol Oncol,2009,113(1):2831. [27] Lowe MP,Chamberlain DH,Kamelle SA,et multiinstitutional experience with roboticassisted radical hysterectomy for early stage cervical cancer[J].Gynecol Oncol，2009，113(2)：191194. [28] Oleszczuk A,Kohler C,Paulick J,et robotassisted radical hysterectomy (VRARH) after laparoscopic staging:feasibility and operative results[J].Int J Med Robot，2009，5(1):3844. [29] Chuang LT,Lerner DL,Liu CS,et sparing roboticassisted radical trachelectomy and bilateral pelvic lymphadenectomy in earlystage cervical cancer[J].J Minim Invasive Gynecol，2008，15(6):767770. [30] Sert BM,Abeler assisted laparoscopic radical hysterectomy (Piver type Ⅲ) with pelvic node dissectioncase report[J].Eur J Gynaecol Oncol，2006，27(5):531533. [31] Ko EM,Muto MG,Berkowitz RS,et versus open radical hysterectomy:a parative study at a single institution[J].Gynecol Oncol，2008，111(3):425430. [32] Pomel C,Rouzier R,Pocard M,et total pelvic exenteration for cervical cancer relapse[J].Gynecol Oncol，2003，91(3):616618. [33] Schneider A,Kohler C,Erdemoglu developments for pelvic exenteration in gynecologic oncology[J].Curr Opin Obstet Gynecol，2009，21(1):49. [34] Lavazzo C,Vorgias G,Akrivos pelvic exenteration:a new option in the surgical treatment of locally advanced and recurrent cervical carcinoma[J].Bratisl Lek Listy,2008，109(10):467469. [35] Ferron G,Querleu D,Martel P,et assisted vaginal pelvic exenteration[J].Gynecol Obstet Fertil，2006，34(12):11311136. [36] Uzan C,Rouzier R,Castaigne D,et pelvic exenteration for cervical cancer relapse:preliminary study[J].J Gynecol Obstet Biol Reprod (Paris)，2006，35(2):136145. [37] Puntambekar S,Kudchadkar RJ,Gurjar AM,et pelvic exenteration for advanced pelvic cancers:a review of 16 cases[J].Gynecol Oncol，2006，102(3):513516.[38] Ferron G,Querleu D,Martel P,et assisted vaginal pelvic exenteration[J].Gynecol Oncol，2006，100(3):551555.申明：本論文版權(quán)歸原刊發(fā)雜志社所有，我們轉(zhuǎn)載的目的是用于 學(xué)術(shù)交流與討論，僅供參考不構(gòu)成任何學(xué)術(shù)建議。內(nèi)容總結(jié)
（1）子宮頸癌的微創(chuàng)手術(shù)治療現(xiàn)狀與進(jìn)展
作者：梁志清 作者單位：第三軍醫(yī)大學(xué)西南醫(yī)院，重慶，400038
【關(guān)鍵詞】 子宮頸癌 微創(chuàng)手術(shù)
子宮頸癌是最常見的女性生殖器官惡性腫瘤，經(jīng)腹廣泛性子宮切除+盆腔淋巴結(jié)切除術(shù)一直是治療早期宮頸癌的標(biāo)準(zhǔn)術(shù)式
（2）腹腔鏡全盆腔切除術(shù)的手術(shù)范圍包括盆腔淋巴結(jié)、膀胱切除、子宮廣泛切除、輸尿管乙狀結(jié)腸吻合、直腸切除、乙狀結(jié)腸及降結(jié)腸造瘺
公司管理相關(guān)推薦
鄂ICP備17016276號-1